Waldron Private Wealth’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,981
| Closed | -$14.7K | – | 430 |
|
|
2023
Q1 | $14.7K | Hold |
3,981
| – | – | ﹤0.01% | 419 |
|
|
2022
Q4 | $31K | Hold |
3,981
| – | – | ﹤0.01% | 363 |
|
|
2022
Q3 | $31K | Hold |
3,981
| – | – | ﹤0.01% | 366 |
|
|
2022
Q2 | $83K | Hold |
3,981
| – | – | ﹤0.01% | 372 |
|
|
2022
Q1 | $149K | Buy |
3,981
+2,977
| +297% | +$111K | 0.01% | 388 |
|
|
2021
Q4 | $56K | Hold |
1,004
| – | – | ﹤0.01% | 370 |
|
|
2021
Q3 | $72K | Hold |
1,004
| – | – | ﹤0.01% | 351 |
|
|
2021
Q2 | $96K | Buy |
+1,004
| New | +$96K | 0.01% | 330 |
|